港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

药明合联

64.350

+0.3500.55%

成交量：83.25万

成交额：5,322.93万

市值：810.81亿

市盈率：50.01

高：64.600

开：64.600

低：63.300

收：64.000

52周最高：85.500

52周最低：30.250

股本：12.60亿

香港流通股本：12.60亿

量比：0.46

换手率：0.07%

股息：- -

股息率：- -

每股收益(LYR):1.287

净资产收益率：17.05%

总资产收益率：8.60%

市净率：6.58

市盈率(LYR):50.01

市销率: 11.87

数据加载中...

总览公司新闻资讯公告

【券商聚焦】国泰海通：AI+制药重塑研发范式行业从概念迈入实效验证期

每日卖空追踪 | 药明合联 03月06日卖空量成交43.7万股，卖空比例为12.89%

【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情

药明合联（02268）2026年2月股份变动月报：股本维持稳定

每日卖空追踪 | 药明合联 03月04日卖空量成交62.85万股，卖空比例为6.62%

药明合联(02268)出现大手卖出23.05万股，成交价$56.3，涉资1.298千万

阿斯达克财经

大摩：药明合联(02268)股价未来30日将绝对上涨

智通财经网

医药行业跟踪报告：中国创新ADC闪耀ASCO GU，长效三靶点减肥药二期临床成功

每日卖空追踪 | 药明合联 03月02日卖空量成交30.3万股，卖空比例为6.7%

【券商聚焦】招银国际：AI将改变创新药物研发范式

《大行》交银国际：药明合联(02268.HK)全球CXO赛道投融资、BD交易延续高活跃度维持“买入”评级

阿斯达克财经

《大行》大摩：药明合联(02268.HK)股价未来30日将绝对上涨

阿斯达克财经

药明合联与Earendil Labs就Wuxitecan-2有效载荷-连接子技术平台达成战略合作

药明合联与Earendil Labs就WuXiTecan-2载荷连接子技术授权达成战略合作

药明合联午前涨近8% 公司有望持续受益XDC CRDMO行业下游需求改善趋势

【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续但仍有短期波动可能

【券商聚焦】交银国际维持药明合联(02268)买入评级指XDC赛道融资/BD开年延续较高热情

港股创新药概念股走强！药明合联涨超7%，云顶新耀、再鼎医药涨近6%

老虎资讯综合

药明合联02月26日主力净流出958.1万元散户资金买入

药明合联盘中异动大幅跳水5.01%报60.700港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02268/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":64.35,"timestamp":1776312300003,"preClose":64,"halted":0,"volume":832512,"delay":0,"changeRate":0.005468749999999911,"floatShares":1260000000,"shares":1260000000,"eps":1.2868515904285311,"marketStatus":"午间休市","change":0.35,"latestTime":"04-16 12:05:00","open":64.6,"high":64.6,"low":63.3,"amount":53229303,"amplitude":0.020312,"askPrice":64.35,"askSize":1500,"bidPrice":64.3,"bidSize":5500,"shortable":3,"etf":0,"ttmEps":1.284940843905648,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776315600000},"marketStatusCode":3,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":64,"openAndCloseTimeList":[[1776303000000,1776312000000],[1776315600000,1776326400000]],"volumeRatio":0.463149,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1260000000,"roa":"8.60%","roe":"17.05%","lyrEps":1.286852,"volumeRatio":0.463149,"shares":1260000000,"dividePrice":0,"high":64.6,"amplitude":0.020312,"preClose":64,"low":63.3,"week52Low":30.25,"pbRate":"6.58","psRate":"11.87","week52High":85.5,"institutionHeld":0,"latestPrice":64.35,"committee":0.571429,"eps":1.2868515904285311,"divideRate":0,"volume":832512,"delay":0,"ttmEps":1.284940843905648,"open":64.6,"prevYearClose":60.75,"prevWeekClose":63,"prevMonthClose":58.2,"prevQuarterClose":58.2,"fiveDayClose":61.15,"twentyDayClose":54.3,"sixtyDayClose":75.75,"earningDate":1777392000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2026-04-29","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1777426200000,"name":null,"time":"","dateTimestamp":1777392000000,"actualEps":null},{"date":"2026-03-23","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-18","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3182,"buy":0.6818,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6818,"analysts":22,"updateTime":1776182400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2026-04-14","current":49.798623,"percent":0.261017,"low":30.568632,"twenty":44.729643,"median":58.079477,"eighty":71.055587,"high":153.052589,"avg":63.542134,"sd":26.041092,"marketCap":80977053812},"quantilePoints":[{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191},{"date":"2025-04-11","current":35.581021,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":40380451549},{"date":"2025-04-17","current":33.597127,"twenty":0.4381,"median":49.700845,"eighty":72.980467,"marketCap":38220427395},{"date":"2025-04-25","current":39.226609,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44663120338},{"date":"2025-05-02","current":40.829264,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":46586700218},{"date":"2025-05-09","current":38.818219,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44603008467},{"date":"2025-05-16","current":39.608151,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":45882474676},{"date":"2025-05-23","current":38.196121,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":44379117053},{"date":"2025-05-30","current":41.172242,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48047309655},{"date":"2025-06-06","current":42.866418,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":50152010328},{"date":"2025-06-13","current":46.041552,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":53888090995},{"date":"2025-06-20","current":41.240748,"twenty":0.437995,"median":49.941945,"eighty":73.022778,"marketCap":48174509918},{"date":"2025-06-27","current":40.971553,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":47994081042},{"date":"2025-07-04","current":46.000985,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":53888090995},{"date":"2025-07-11","current":47.288014,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":55339986740},{"date":"2025-07-18","current":50.925924,"twenty":0.438098,"median":50.569275,"eighty":72.98104,"marketCap":59550637905},{"date":"2025-07-25","current":57.660678,"twenty":0.438098,"median":51.683826,"eighty":72.98104,"marketCap":67671179437},{"date":"2025-08-01","current":57.245588,"twenty":0.438098,"median":52.545804,"eighty":72.98104,"marketCap":66768897045},{"date":"2025-08-08","current":57.73965,"twenty":0.43811,"median":53.257543,"eighty":72.98104,"marketCap":67513611340},{"date":"2025-08-15","current":64.222783,"twenty":31.309336,"median":54.856958,"eighty":72.98104,"marketCap":74981664691},{"date":"2025-08-22","current":48.130228,"twenty":34.419063,"median":54.952855,"eighty":72.98104,"marketCap":69501077151},{"date":"2025-08-29","current":46.988345,"twenty":35.581021,"median":54.952855,"eighty":72.98104,"marketCap":68176099944},{"date":"2025-09-05","current":54.370406,"twenty":36.186031,"median":55.113399,"eighty":72.98104,"marketCap":78808670381},{"date":"2025-09-12","current":57.034752,"twenty":36.596757,"median":55.50873,"eighty":72.98104,"marketCap":82819396110},{"date":"2025-09-19","current":59.571504,"twenty":36.911418,"median":56.000464,"eighty":72.98104,"marketCap":86441593568},{"date":"2025-09-26","current":63.204858,"twenty":37.279949,"median":56.495601,"eighty":72.98104,"marketCap":91475834102},{"date":"2025-10-03","current":72.025865,"twenty":37.670679,"median":56.699916,"eighty":72.980467,"marketCap":104491187679},{"date":"2025-10-10","current":60.90024,"twenty":38.189538,"median":56.97042,"eighty":72.98104,"marketCap":88221995708},{"date":"2025-10-17","current":57.936353,"twenty":38.732076,"median":57.121577,"eighty":72.98104,"marketCap":83863080123},{"date":"2025-10-24","current":59.821834,"twenty":39.226609,"median":57.526112,"eighty":72.98104,"marketCap":86623810506},{"date":"2025-10-31","current":63.630196,"twenty":39.774995,"median":57.92353,"eighty":72.98104,"marketCap":92275860553},{"date":"2025-11-07","current":58.827143,"twenty":40.354886,"median":58.251953,"eighty":72.98104,"marketCap":85257233036},{"date":"2025-11-14","current":59.953959,"twenty":41.172242,"median":58.455089,"eighty":72.98104,"marketCap":87136525462},{"date":"2025-11-21","current":57.356344,"twenty":41.596291,"median":58.554061,"eighty":72.98104,"marketCap":83322340564},{"date":"2025-11-28","current":56.291024,"twenty":42.018405,"median":58.564991,"eighty":72.98104,"marketCap":82071768197},{"date":"2025-12-05","current":57.95451,"twenty":42.42494,"median":58.564991,"eighty":72.98104,"marketCap":84642388897},{"date":"2025-12-12","current":56.819112,"twenty":42.866418,"median":58.860686,"eighty":72.98104,"marketCap":83137635317},{"date":"2025-12-19","current":59.902097,"twenty":43.024716,"median":58.930609,"eighty":72.98104,"marketCap":87855221510},{"date":"2025-12-24","current":53.787136,"twenty":43.211711,"median":58.930609,"eighty":72.98104,"marketCap":79132453088},{"date":"2026-01-02","current":52.131715,"twenty":43.875774,"median":58.940897,"eighty":73.022778,"marketCap":76998826280},{"date":"2026-01-09","current":60.097118,"twenty":44.079539,"median":58.920321,"eighty":72.979321,"marketCap":88984788643},{"date":"2026-01-16","current":59.868148,"twenty":44.329264,"median":59.011667,"eighty":72.978748,"marketCap":88933823858},{"date":"2026-01-23","current":58.064858,"twenty":44.542103,"median":59.011667,"eighty":72.978748,"marketCap":86172293688},{"date":"2026-01-30","current":52.991062,"twenty":44.673253,"median":58.945496,"eighty":72.939295,"marketCap":79001941874},{"date":"2026-02-06","current":53.067413,"twenty":44.72485,"median":58.907275,"eighty":72.769063,"marketCap":79316440050},{"date":"2026-02-13","current":54.647287,"twenty":44.764796,"median":58.707371,"eighty":72.713983,"marketCap":82146923636},{"date":"2026-02-20","current":54.893728,"twenty":44.79956,"median":58.576126,"eighty":72.595053,"marketCap":82398522177},{"date":"2026-02-27","current":52.350133,"twenty":44.938454,"median":58.531174,"eighty":72.112603,"marketCap":79442239320},{"date":"2026-03-06","current":49.767005,"twenty":45.116803,"median":58.469542,"eighty":72.01889,"marketCap":74913465582},{"date":"2026-03-13","current":45.00506,"twenty":45.116803,"median":58.377121,"eighty":71.985255,"marketCap":68057405340},{"date":"2026-03-20","current":44.215816,"twenty":45.114658,"median":58.350601,"eighty":71.8872,"marketCap":66610713729},{"date":"2026-03-27","current":44.200592,"twenty":44.738431,"median":58.251953,"eighty":71.510989,"marketCap":74095770324},{"date":"2026-04-02","current":45.669591,"twenty":44.705679,"median":58.178024,"eighty":71.208025,"marketCap":76926253910},{"date":"2026-04-10","current":46.69114,"twenty":44.720057,"median":58.083986,"eighty":71.116562,"marketCap":79253540415},{"date":"2026-04-14","current":47.593678,"twenty":44.729643,"median":58.079477,"eighty":71.055587,"marketCap":80977053812}],"updateTime":1776285507391},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618607744","title":"【券商聚焦】国泰海通：AI+制药重塑研发范式 行业从概念迈入实效验证期","url":"https://stock-news.laohu8.com/highlight/detail?id=2618607744","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618607744?lang=zh_cn&edition=fundamental","pubTime":"2026-03-10 11:27","pubTimestamp":1773113233,"startTime":"0","endTime":"0","summary":"随着AI在靶点发现、分子生成、临床设计及上市后数据分析中的全面渗透，行业渗透率持续提升，AI+制药正成为创新药研发的重要基础设施。整体来看，AI正在成为药物研发体系升级的核心变量。在人工智能与医药双领域共振下，该机构看好AI+制药发展前景。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjZhZmU5OWE5M2M5YjFiNzE1NDI2Mjg5NzQxNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976200","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1197","LU0348825331.USD","LU1115378108.SGD","01477","01099","02268","01789","IE00BPRC5H50.USD","BK1161","09926","LU0634319403.HKD","LU0561508036.HKD","LU0640798160.USD","SG9999004311.SGD","03933","BK0028","LU0417516902.SGD","BK1585","02611","LU2476274308.USD","LU2488822045.USD","02196","SG9999014674.SGD","LU0417516738.SGD","09688","IE00B5MMRT66.SGD","BK1515","HK0000165453.HKD","LU0348783233.USD","BK1564","LU1303224171.USD","LU0348735423.USD","LU0588546209.SGD","06160","02228","LU0348784397.USD","LU1251922891.USD","LU0348767384.USD","BK1593","LU0348827113.USD","BK1500","LU0307460666.USD","LU1720050803.USD","LU2476274720.SGD","601211","BK1100","BK0276","02367","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617865322","title":"每日卖空追踪 | 药明合联 03月06日卖空量成交43.7万股，卖空比例为12.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617865322","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617865322?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 16:30","pubTimestamp":1772785828,"startTime":"0","endTime":"0","summary":"药明合联北京时间03月06日，涨3.3%，卖空量成交43.7万股，较上一交易日减少74.28%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163343a4535b89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163343a4535b89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617919503","title":"【券商聚焦】交银国际：医药公司业绩兑现有望催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2617919503","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617919503?lang=zh_cn&edition=fundamental","pubTime":"2026-03-06 09:08","pubTimestamp":1772759313,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，2026年以来，内资通过港股通持有医药股的比例呈现先降后升态势，当前水平与年初持平，外资持仓则有所提升。本周内资继续加仓创新药产业链和器械标的，外资则重点布局创新药企及CXO企业。年报季临近，本周各公司业绩预告陆续发布，该机构建议持续关注财务表现超预期、盈利路径清晰的公司，其业绩兑现有望催化板块行情。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWIyNWQwZjQ4NTQyNjI4OTI5NDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976027","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","03933","03329","HK0000165453.HKD","IE00BPRC5H50.USD","LU0540923850.HKD","LU0588546209.SGD","LU1961090484.USD","LU2399975544.HKD","LU0348827113.USD","09926","09688","LU2476274308.USD","LU1719994722.HKD","SG9999014674.SGD","02196","01789","BK1593","LU1770034418.SGD","06160","02228","BK1141","LU0348784397.USD","SG9999004311.SGD","LU0561508036.HKD","LU0640798160.USD","LU2778985437.USD","BK1207","LU0348735423.USD","LU2488822045.USD","01530","LU2328871848.SGD","02367","BK1191","09939","BK1585","159938","LU0417516571.SGD","LU2476274720.SGD","LU1794554557.SGD","LU0348783233.USD","BK1197","LU1303224171.USD","01099","IE00B5MMRT66.SGD","LU0348825331.USD","LU1115378108.SGD","BK1515","LU0348766576.USD","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193876028","title":"药明合联（02268）2026年2月股份变动月报：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1193876028","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193876028?lang=zh_cn&edition=fundamental","pubTime":"2026-03-05 17:19","pubTimestamp":1772702347,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman Inc.于2026年3月5日披露2026年2月股份变动月报表。公告显示，截至2026年2月底，公司股本结构整体保持稳定，未有新增发行或回购活动。已发行股份总数维持在1,257,992,705股，库藏股份数量为0，未发生变动。此外，公司于2024年股份计划下已批准授出尚未发行的普通股累计10,285,226股，本月同样无变动。公司声明已遵守香港联交所《主板上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7babad1b4c042890cc8c6c387e110b44","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617308590","title":"每日卖空追踪 | 药明合联 03月04日卖空量成交62.85万股，卖空比例为6.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617308590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617308590?lang=zh_cn&edition=fundamental","pubTime":"2026-03-04 16:30","pubTimestamp":1772613028,"startTime":"0","endTime":"0","summary":"药明合联北京时间03月04日，跌5.41%，卖空量成交62.85万股，较上一交易日减少41.7%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163411a44a6e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163411a44a6e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616304985","title":"药明合联(02268)出现大手卖出23.05万股，成交价$56.3，涉资1.298千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2616304985","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616304985?lang=zh_cn&edition=fundamental","pubTime":"2026-03-04 10:05","pubTimestamp":1772589900,"startTime":"0","endTime":"0","summary":"[大手成交]药明合联(02268)在上午10:05出现大手卖出，成交量为23.05万，成交价为港币$56.3，涉资1.298千万。至目前为止，股价跌4.73%，今日最高价为$59.15，而最低价为$56.15，总成交量为195.572万股，总成交金额港币$1.129亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603044775/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2603044775/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616306232","title":"大摩：药明合联(02268)股价未来30日将绝对上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2616306232","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616306232?lang=zh_cn&edition=fundamental","pubTime":"2026-03-03 17:27","pubTimestamp":1772530053,"startTime":"0","endTime":"0","summary":"该行给予药明合联目标价为86港元，其评级为“增持”。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260303/20260303172831_42715.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260303/20260303172831_42715.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2488822045.USD","02268","SG9999014674.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616596093","title":"医药行业跟踪报告：中国创新ADC闪耀ASCO GU，长效三靶点减肥药二期临床成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2616596093","media":"爱建证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616596093?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 22:06","pubTimestamp":1772460407,"startTime":"0","endTime":"0","summary":"投资要点：医药板块行情复盘：本周为春节假期后第一周，市场温和反弹，沪深300指数+1.08%，但A股医药板块整体表现平淡，SW医药生物指数+0.50%，在申万一级行业指数中排名25/31。中国创新ADC闪耀ASCOGU，映恩DB-1311生存获益数据优异。联邦三靶点减肥药UBT251二期临床成功，将尽快启动三期临床研究。2月24日，联邦制药发布公告，其自主研发的长效GLP-1/GIP/GCG三靶点激动剂UBT251注射液已完成在中国超重/肥胖患者中的二期临床研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302220654a699592f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302220654a699592f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","03933","BK1191","09926","09606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616318201","title":"每日卖空追踪 | 药明合联 03月02日卖空量成交30.3万股，卖空比例为6.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616318201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616318201?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 16:30","pubTimestamp":1772440232,"startTime":"0","endTime":"0","summary":"药明合联北京时间03月02日，跌2.77%，卖空量成交30.3万股，较上一交易日减少69.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163437a730c74d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302163437a730c74d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616538865","title":"【券商聚焦】招银国际：AI将改变创新药物研发范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538865","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616538865?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 14:40","pubTimestamp":1772433633,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际表示，MSCI中国医疗指数2026年初至今累计上涨5.0%，跑赢MSCI中国指数6.2%。医药行业近期明显回调（MSCI中国医疗指数1月15日至今累计下跌9%），特别是创新药板块回调幅度较大（恒生生物科技指数1月15日至今累计下跌13%）。该机构认为，此轮调整原因包括博弈层面行业短期缺乏催化剂，以及行业轮动导致资金流出医药板块。中国创新药资产出海BD持续超预期，MNC对于中国资产的购买范围从单个管线拓宽至平台合作，进一步体现了中国创新药的竞争力。该机构认为，中国的AI制药技术发展迅猛，将涌现一批优秀的创新企业。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/M2QyMTYxN2UxNmI4NDk2OTg5NThlNDVhNTUzNjZhZTcxMjcxMzE0NDc4MDA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2476274720.SGD","LU0588546209.SGD","01789","09926","BK1617","LU0640798160.USD","LU2399975544.HKD","LU0348735423.USD","LU2488822045.USD","02367","HK0000165453.HKD","BK1100","LU0561508036.HKD","06160","02228","LU1961090484.USD","BK1197","LU1794554557.SGD","BK1207","01530","01099","LU0348827113.USD","IE00B543WZ88.USD","02268","159992","02196","03933","LU0348825331.USD","LU2328871848.SGD","SG9999014674.SGD","IE00BPRC5H50.USD","SG9999004311.SGD","06978","09688","BK1141","IE00B5MMRT66.SGD","LU1115378108.SGD","LU1720050803.USD","BK1583","LU1969619763.USD","LU1251922891.USD","BK1515","BK1574","LU0634319403.HKD","LU1303224171.USD","LU0348784397.USD","LU0307460666.USD","BK1585","LU0348783233.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616800129","title":"《大行》交银国际：药明合联(02268.HK)全球CXO赛道投融资、BD交易延续高活跃度 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2616800129","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616800129?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 14:09","pubTimestamp":1772431740,"startTime":"0","endTime":"0","summary":"交银国际研究报告指出，药明合联作为反映CRDMO业务需求的先行指标，全球CXO赛道的投融资和BD交易在2026年初延续了过去两年的极高活跃度。交银国际的目标价为91港元，对应2026年市盈率42倍，维持“买入”评级，考虑到公司在高景气度的XDC CRDMO赛道中稳居全球领先地位、当前投资性价比极高，继续将公司选为CXO行业重点推荐标的。沽空资料截至 2026-03-02 12:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104105862_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505890/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505890/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616580103","title":"《大行》大摩：药明合联(02268.HK)股价未来30日将绝对上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2616580103","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616580103?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 11:58","pubTimestamp":1772423880,"startTime":"0","endTime":"0","summary":"摩根士丹利发表技术意见报告，相信药明合联(02268.HK) 股价在未来30日将绝对上涨，主要是该股近期交易价格下跌，令短期估值更具吸引力。药明康德宣布一项涉及其有效载荷连接子技术平台的规模可观的对外授权协议。此类协议包括预付款、里程碑付款以及潜在的销售分成，这些都将有助于提升销售额和盈利能力。该行给予药明合联目标价为86元，其评级为“增持”。(ca/w)(港股报价延迟最少十五分钟。沽空资料截至 2026-02-27 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20231117104101799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505845/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1505845/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193991119","title":"药明合联与Earendil Labs就Wuxitecan-2有效载荷-连接子技术平台达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1193991119","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193991119?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 17:14","pubTimestamp":1772183652,"startTime":"0","endTime":"0","summary":"药明合联（WuXi XDC）宣布与Earendil Labs建立战略合作伙伴关系，双方将围绕Wuxitecan-2有效载荷-连接子技术平台展开深度协作。此次合作旨在整合彼此在生物偶联技术领域的优势资源，共同推进新型抗体偶联药物（ADC）技术的开发与应用。\n通过本次战略联手，药明合联将借助Earendil Labs在创新有效载荷-连接子技术方面的专长，进一步拓展其ADC技术平台的能力边界。Wuxitecan-2作为新一代拓扑异构酶I抑制剂有效载荷，具有显著的治疗潜力，这项合作将加速其在癌症治疗领域的创新应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614154831","title":"药明合联与Earendil Labs就WuXiTecan-2载荷连接子技术授权达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2614154831","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614154831?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 17:11","pubTimestamp":1772183460,"startTime":"0","endTime":"0","summary":"上海2026年2月27日 /美通社/ -- 全球领先的专注于提供抗体偶联药物等生物偶联药物端到端CRDMO服务的药明合联，今日宣布与Earendil Labs就药明合联自主研发的WuXiTecan-2载荷连接子技术授权达成战略合作。Earendil Labs利用其独特的AI平台生成了具有差异化优势的双特异性抗体，与我们的WuXiTecan-2载荷连接子技术联用，有望开发出更有效、更安全的下一代ADC药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4897609_ZH97609_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045007","title":"药明合联午前涨近8% 公司有望持续受益XDC CRDMO行业下游需求改善趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045007","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045007?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 11:55","pubTimestamp":1772164500,"startTime":"0","endTime":"0","summary":"　　药明合联盘中涨超8%，截至发稿，股价上涨7.54%，现报62.75港元，成交额3.01亿港元。2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-27/doc-inhpfnzn6798937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268","BK1141","SG9999014674.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续 但仍有短期波动可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614009267?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周2026ASCOGU大会常规摘要公布，此次大会将于本月2628号召开，共有超过70项我国专家主导的研究入选，荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相，临床数据密集释放有望阶段性催化板块行情。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1197","LU0540923850.HKD","LU0348825331.USD","BK1588","01099","02268","IE00BPRC5H50.USD","01789","BK1161","LU2778985437.USD","09926","LU0634319403.HKD","LU0640798160.USD","03933","LU0417516902.SGD","IE00B543WZ88.USD","LU2476274308.USD","LU2488822045.USD","02196","BK1207","LU0417516738.SGD","SG9999014674.SGD","09688","BK1515","HK0000165453.HKD","159938","LU0588546209.SGD","BK1617","BK1191","06160","02228","LU0348784397.USD","LU1794554557.SGD","LU0348766576.USD","LU1251922891.USD","LU0348767384.USD","LU2399975544.HKD","03329","LU0348827113.USD","09939","BK1141","LU1720050803.USD","LU2476274720.SGD","BK1147","LU1961090484.USD","BK1100","LU1770034418.SGD","02367","LU0417516571.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614697009","title":"【券商聚焦】交银国际维持药明合联(02268)买入评级 指XDC赛道融资/BD开年延续较高热情","url":"https://stock-news.laohu8.com/highlight/detail?id=2614697009","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614697009?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 09:43","pubTimestamp":1772156610,"startTime":"0","endTime":"0","summary":"2024年年初以来，XDC领域投融资事件数、BD交易数和首付款总额呈逐步上升态势。投融资和BD交易持续活跃，将进一步拉动XDC CRDMO行业下游需求改善，药明合联作为技术实力和一体化交付能力布局的龙头企业，有望持续受益于这一重要趋势、并扩大市场份额。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/NGZhNmEwMzJkNDhkNWE0NjE0NjM0MTA4NTA5NzI5NDQz.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975587","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128119023","title":"港股创新药概念股走强！药明合联涨超7%，云顶新耀、再鼎医药涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128119023","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128119023?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 09:40","pubTimestamp":1772156400,"startTime":"0","endTime":"0","summary":"2月27日，港股创新药概念股走强，$药明合联(02268)$涨超7%，$云顶新耀(01952)$、$再鼎医药(ZLAB)$涨近6%，$康方生物(09926)$、$药明生物(02269)$涨超4%，$歌礼制药-B(01672)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9a5adfc15d956a00313fe91052a1cff8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1583","VT","LU2488822045.USD","BK4526","BK1588","06978","BK4548","BK4139","ZLAB","SG9999014674.SGD","BK1161","BK4531","BK1574","09688","VXUS","01952","BK4588","159992","BK4585","02268"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614567008","title":"药明合联02月26日主力净流出958.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614567008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614567008?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 16:15","pubTimestamp":1772093752,"startTime":"0","endTime":"0","summary":"02月26日, 药明合联股价跌8.69%，报收58.35元，成交金额5.0亿元，换手率0.66%，振幅10.41%，量比3.95。药明合联今日主力资金净流出958.1万元，上一交易日主力净流入335.0万元。该股近5个交易日下跌10.08%，主力资金累计净流出1675.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5857.5万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226162012a4caa49b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","SG9999014674.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614008526","title":"药明合联盘中异动 大幅跳水5.01%报60.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614008526?lang=zh_cn&edition=fundamental","pubTime":"2026-02-26 14:06","pubTimestamp":1772085973,"startTime":"0","endTime":"0","summary":"2026年02月26日下午盘14时06分，药明合联股票出现波动，股价大幅下挫5.01%。截至发稿，该股报60.700港元/股，成交量429.846万股，换手率0.34%，振幅5.71%。资金方面，该股资金流入9895.07万港元，流出1.2869亿港元。药明合联股票所在的生物技术行业中，整体跌幅为3.94%。其相关个股中，百奥赛图-B、药捷安康-B、思路迪医药股份涨幅较大，振幅较大的相关个股有三叶草生物-B、百奥赛图-B、药捷安康-B，振幅分别为11.96%、11.38%、9.90%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226140613a4ca28ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","BK1141","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}